A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Incyte Corporation
Pfizer
Pfizer
NuCana plc
University of Virginia
Molecular Templates, Inc.
Inhibrx Biosciences, Inc
University of Florida
Fate Therapeutics
Advaxis, Inc.
Rubius Therapeutics
Duke University
Genocea Biosciences, Inc.
Incyte Corporation
Hoffmann-La Roche